Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains

Journal of Autoimmunity

Volumn 33, Issue 1, 2009, Pages 42-49

  Zhang, Li ^a   Jasinski, Jean M ^a   Kobayashi, Masakazu ^a   Davenport, Bennett ^a   Johnson, Kelly ^a   Davidson, Howard ^a   Nakayama, Maki ^a   Haskins, Kathryn ^b   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Insulin; T cell Receptor; Type 1 diabetes

Indexed keywords

INSULIN ANTIBODY; INSULIN DERIVATIVE; INSULIN PEPTIDE B (9-23); T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOMINANT GENE; GENE SEQUENCE; GENETIC CONSERVATION; HYBRIDOMA; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; CONSERVED SEQUENCE; DIABETES MELLITUS, TYPE 1; EPITOPE MAPPING; HYBRIDOMAS; IMMUNODOMINANT EPITOPES; INSULIN; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES;

EID: 67349111962     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.003     Document Type: Article

References (46)

1. Baschal E.E., and Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 31 (2008) 1-6
2. Moriyama H., Wen L., Abiru N., Liu E., Yu L., Miao D., et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A 99 (2002) 5539-5544
3. Devendra D., Paronen J., Moriyama H., Miao D., Eisenbarth G.S., and Liu E. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes. J Autoimmun 23 (2004) 17-26
4. Urbanek-Ruiz I., Ruiz P.J., Paragas V., Garren H., Steinman L., and Fathman C.G. Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. Clin Immunol 100 (2001) 164-171
5. Daniel D., and Wegmann D.R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A 93 (1996) 956-960
6. Nakayama M., Beilke J.N., Jasinski J.M., Kobayashi M., Miao D., Li M., et al. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 117 (2007) 1835-1843
7. Mukherjee R., Chaturvedi P., Qin H.Y., and Singh B. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. J Autoimmun 21 (2003) 221-237
8. Paronen J., Liu E., Moriyama H., Devendra D., Ide A., Taylor R., et al. Genetic differentiation of Poly I:C from B:9-23 peptide induced experimental autoimmune diabetes. J Autoimmun 22 (2004) 307-313
9. Moriyama H., Abiru N., Paronen J., Sikora K., Liu E., Miao D., et al. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci U S A 100 (2003) 10376-10381
10. Simone E., Daniel D., Schloot N., Gottlieb P., Babu S., Kawasaki E., et al. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci U S A 94 (1997) 2518-2521
11. Abiru N., Maniatis A.K., Yu L., Miao D., Moriyama H., Wegmann D., et al. Peptide and MHC specific breaking of humoral tolerance to native insulin with the B:9-23 peptide in diabetes prone and normal mice. Diabetes 50 (2001) 1274-1281
12. Lieberman S.M., and DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62 (2003) 359-377
13. Suri A., Levisetti M.G., and Unanue E.R. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?. Curr Opin Immunol 20 (2008) 105-110
14. Villano MJ, Huber AK, Greenberg DA, Golden BK, Concepcion E, Tomer Y. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab in press, doi:10.1210/jc.2008-2193
15. Daniel D., Gill R.G., Schloot N., and Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25 (1995) 1056-1062
16. Jasinski J.M., Yu L., Nakayama M., Li M.M., Lipes M.A., Eisenbarth G.S., et al. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 55 (2006) 1978-1984
17. DiLorenzo T.P., and Serreze D.V. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 204 (2005) 250-263
18. Chen W., Bergerot I., Elliott J.F., Harrison L.C., Abiru N., Eisenbarth G.S., et al. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 167 (2001) 4926-4935
19. Wong F.S., Karttunen J., Dumont C., Wen L., Visintin I., Pilip I.M., et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 5 (1999) 1026-1031
20. Trudeau J.D., Kelly-Smith C., Verchere C.B., Elliott J.F., Dutz J.P., Finegood D.T., et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111 (2003) 217-223
21. Zhang L., Nakayama M., and Eisenbarth G.S. Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 20 (2008) 111-118
22. Wegmann D.R., Norbury-Glaser M., and Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 24 (1994) 1853-1857
23. Zhang L., Gianani R., Nakayama M., Liu E., Kobayashi M., Baschal E., et al. Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp 292 (2008) 85-94
24. Alleva D.G., Gaur A., Jin L., Wegmann D., Gottlieb P.A., Pahuja A., et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 51 (2002) 2126-2134
25. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435 (2005) 220-223
26. Du W., Wong F.S., Li M.O., Peng J., Qi H., Flavell R.A., et al. TGF-beta signaling is required for the function of insulin-reactive T regulatory cells. J Clin Invest 116 (2006) 1360-1370
27. Fife B.T., Guleria I., Gubbels B.M., Eagar T.N., Tang Q., Bour-Jordan H., et al. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 203 (2006) 2737-2747
28. Alleva D.G., Crowe P.D., Jin L., Kwok W.W., Ling N., Gottschalk M., et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 107 (2001) 173-180
29. Mallone R., Martinuzzi E., Blancou P., Novelli G., Afonso G., Dolz M., et al. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 56 (2007) 613-621
30. Pinkse G.G., Tysma O.H., Bergen C.A., Kester M.G., Ossendorp F., van Veelen P.A., et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102 (2005) 18425-18430
31. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435 (2005) 224-228
32. Toma A., Haddouk S., Briand J.P., Camoin L., Gahery H., Connan F., et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A 102 (2005) 10581-10586
33. Skowera A., Ellis R.J., Varela-Calvino R., Arif S., Huang G.C., Van-Krinks C., et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 118 (2008) 3390-3402
34. Krishnamurthy B., Dudek N.L., McKenzie M.D., Purcell A.W., Brooks A.G., Gellert S., et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 116 (2006) 3258-3265
35. Moriyama H., Nagata M., Arai T., Okumachi Y., Yamada K., Kotani R., et al. Insulin as a T cell antigen in type 1 diabetes supported by the evidence from the insulin knockout NOD mice. Diabetes Res Clin Pract 77 Suppl 1 (2007) S155-S160
36. Jaeckel E., Lipes M.A., and von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 5 (2004) 1028-1035
37. Burton A.R., Vincent E., Arnold P.Y., Lennon G.P., Smeltzer M., Li C.S., et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57 (2008) 1321-1330
38. Simone E.A., Yu L., Wegmann D.R., and Eisenbarth G.S. T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice. J Autoimmun 10 (1997) 317-321
39. Kobayashi M., Jasinski J., Liu E., Li M., Miao D., Zhang L., et al. Conserved T cell receptor alpha-chain induces insulin autoantibodies. Proc Natl Acad Sci U S A 105 (2008) 10090-10094
40. Karttunen J., and Shastri N. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci U S A 88 (1991) 3972-3976
41. Fiering S., Northrop J.P., Nolan G.P., Mattila P.S., Crabtree G.R., and Herzenberg L.A. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev 4 (1990) 1823-1834
42. Sanderson S., and Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 6 (1994) 369-376
43. Letourneur F., and Malissen B. Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin. Eur J Immunol 19 (1989) 2269-2274
44. Holst J., Szymczak-Workman A.L., Vignali K.M., Burton A.R., Workman C.J., and Vignali D.A. Generation of T-cell receptor retrogenic mice. Nat Protoc 1 (2006) 406-417
45. Yoshida K., Martin T., Yamamoto K., Dobbs C., Munz C., Kamikawaji N., et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int Immunol 14 (2002) 1439-1447
46. Hahn M., Nicholson M.J., Pyrdol J., and Wucherpfennig K.W. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 6 (2005) 490-496